Literature DB >> 6985991

HLA-A28 and steroid-induced diabetes in renal transplant patients.

D S David, J S Cheigh, D W Braun, M Fotino, K H Stenzel, A L Rubin.   

Abstract

Between July 1971 and March 1977, steroid-induced diabetes (SD) developed postoperatively in 31 (10.8%) of 286 nondiabetic adult kidney transplant recipients who were observed for a total of 410 patient transplant years. There was a highly significant association between HLA-A28 and SD. There was no significant association between SD and BB or Bw 15. Age was also associated with SD. However, A28 was associated with SD even when corrected for age. A28 occurred more frequently in blacks than whites, 25.4% and 6.3%, respectively, and accounted for the higher incidence of SD in black adults. There were no significant associations between SD and patients' sex, donor source, number of short-term rejection treatments, or maintenance dose of corticosteroids. Steroid-induced diabetes had no adverse effects on graft or patient survival.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985991

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.

Authors:  C Ricordi; Y Zeng; R Alejandro; A Tzakis; P Carroll; H L Rilo; R Venkataramanan; J J Fung; D Bereiter; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 3.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  In vivo effect of FK506 on human pancreatic islets.

Authors:  C Ricordi; Y J Zeng; R Alejandro; A Tzakis; R Venkataramanan; J Fung; D Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-09       Impact factor: 4.939

Review 5.  Post-transplant diabetes mellitus. The role of immunosuppression.

Authors:  R M Jindal; R A Sidner; M L Milgrom
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

6.  Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation.

Authors:  Young-Kyu Kim; Kwang-Woong Lee; Seong Hoon Kim; Seong Yeon Cho; Sung-Sik Han; Sang-Jae Park
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

7.  HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes.

Authors:  Nuvreen Phagura; Azm Hussain; Alice Culliford; James Hodson; Felicity Evison; Suzy Gallier; Richard Borrows; Hanna A Lane; David Briggs; Adnan Sharif
Journal:  Transplant Direct       Date:  2021-07-23

8.  Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.

Authors:  H A Chakkera; R L Hanson; S M Raza; J K DiStefano; M P Millis; R L Heilman; D C Mulligan; K S Reddy; M J Mazur; K Hamawi; A A Moss; K L Mekeel; J R Cerhan
Journal:  Transplant Proc       Date:  2009-12       Impact factor: 1.066

9.  Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

Authors:  Olwyn Johnston; Caren L Rose; Angela C Webster; John S Gill
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 10.  New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy.

Authors:  Ali R Chaitou; Surbhi Valmiki; Mrinaal Valmiki; Maria Zahid; Mohamed A Aid; Peter Fawzy; Safeera Khan
Journal:  Cureus       Date:  2022-03-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.